Effect of theinvitroactivity of a component derived fromThymus vulgarisessential oil and tilmicosin on different strains ofStaphylococcus sp,Streptococcus spandEscherichia coliisolated from bovine mastitis / Lysett Corona-Gómez, Laura Hernández-Andrade, Susana Mendoza-Elvira, Daniel Israel Ricardo-González, Malva Dánae Pérez-Gerardo, David Quintanar-Guerrero
ABSTRACT Currently, resistance to antibiotics and the high production of bacterial biofilm have led to the search for new therapeutic alternatives in the veterinary area. The objective of this study was to determine the antimicrobial effect of thymol (a bactericidal component of the essential oil of Thymus vulgaris ) and tilmicosin, and mixtures of both substances, on strains of Staphylococcus sp., Streptococcus sp. and Escherichia coli isolated from cases of bovine mastitis, showing a high production of biofilm in gram-positive bacteria and resistance to aminoglycosides, while gram-negative bacteria a moderate production of biofilm and resistance to ampicillin. An additive effect was obtained with the active mixtures in the three bacterial genera.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:34 |
---|---|
Enthalten in: |
The Journal of essential oil research - 34(2022), 3, Seite 270-277 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Corona-Gómez, Lysett [VerfasserIn] |
---|
Links: |
FID Access [lizenzpflichtig] |
---|
Themen: |
Bovine mastitis |
---|
Umfang: |
1 Online-Ressource (8 p) |
---|
doi: |
10.1080/10412905.2022.2050314 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
KFL011137150 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | KFL011137150 | ||
003 | DE-627 | ||
005 | 20230713210911.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230609s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/10412905.2022.2050314 |2 doi | |
035 | |a (DE-627)KFL011137150 | ||
035 | |a (KFL)prod_LgpH_10.1080/10412905.2022.2050314 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
084 | |a PHARM |q DE-84 |2 fid | ||
100 | 1 | |a Corona-Gómez, Lysett |e verfasserin |4 aut | |
245 | 1 | 0 | |a Effect of theinvitroactivity of a component derived fromThymus vulgarisessential oil and tilmicosin on different strains ofStaphylococcus sp,Streptococcus spandEscherichia coliisolated from bovine mastitis |c Lysett Corona-Gómez, Laura Hernández-Andrade, Susana Mendoza-Elvira, Daniel Israel Ricardo-González, Malva Dánae Pérez-Gerardo, David Quintanar-Guerrero |
264 | 1 | |c 2022 | |
300 | |a 1 Online-Ressource (8 p) | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a ABSTRACT Currently, resistance to antibiotics and the high production of bacterial biofilm have led to the search for new therapeutic alternatives in the veterinary area. The objective of this study was to determine the antimicrobial effect of thymol (a bactericidal component of the essential oil of Thymus vulgaris ) and tilmicosin, and mixtures of both substances, on strains of Staphylococcus sp., Streptococcus sp. and Escherichia coli isolated from cases of bovine mastitis, showing a high production of biofilm in gram-positive bacteria and resistance to aminoglycosides, while gram-negative bacteria a moderate production of biofilm and resistance to ampicillin. An additive effect was obtained with the active mixtures in the three bacterial genera | ||
653 | |a Bovine mastitis | ||
653 | |a tilmicosin | ||
653 | |a thymol | ||
653 | |a Staphylococcussp | ||
653 | |a Streptococcussp.,E. coli | ||
700 | 1 | |a Hernández-Andrade, Laura |e verfasserin |4 aut | |
700 | 1 | |a Mendoza-Elvira, Susana |e verfasserin |4 aut | |
700 | 1 | |a Ricardo-González, Daniel Israel |e verfasserin |4 aut | |
700 | 1 | |a Pérez-Gerardo, Malva Dánae |e verfasserin |4 aut | |
700 | 1 | |a Quintanar-Guerrero, David |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of essential oil research |d London [u.a.] : Taylor & Francis, 1989 |g 34(2022), 3, Seite 270-277 |h Online-Ressource |w (DE-627)KFL00008865X |w (DE-600)2197652-1 |w (DE-576)276559592 |x 2163-8152 |7 nnns |
773 | 1 | 8 | |g volume:34 |g year:2022 |g number:3 |g pages:270-277 |
856 | 4 | 0 | |u http://pharmazie.proxy.fid-lizenzen.de/fid/tandf-ejournals-pharmazie/doi.org/10.1080/10412905.2022.2050314 |m X:KFL |x Resolving-System |y FID Access |z lizenzpflichtig |
912 | |a ZDB-1-TFE | ||
912 | |a GBV_KFL | ||
912 | |a FID-PHARM | ||
935 | |i IMPORT_0628_prod_LgpH_05 | ||
951 | |a AR | ||
952 | |d 34 |j 2022 |e 3 |h 270-277 |